Loading company details...
Beta
Latest Form 4 (Sep 9, 2026): Albert Luderer (Interim Chief Executive): Purchase of 4,000 shares, $4.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 9, 2026 | Albert Luderer, Interim Chief Executive | Purchase | 4,000 | $4.8K |
| Aug 21, 2026 | Albert Luderer, Interim Chief Executive | Purchase | 4,000 | $4.9K |
| Aug 5, 2026 | Mark Adamchak, Principal Accounting Officer | Grant/Award | 5,000 | n/a |
| Aug 5, 2026 | Jonathan Dixon V., General Counsel | Grant/Award | 15,000 | n/a |
| Aug 5, 2026 | Mark Oldakowski, Chief Operating Officer | Grant/Award | 15,000 | n/a |
| Aug 5, 2026 | Alex Reid Hastie, Chief Scientific Officer | Grant/Award | 54,000 | n/a |
| Jun 4, 2026 | Jonathan Dixon V., GENERAL COUNSEL | Tax Withholding | 24 | $31.20 |
| Jun 4, 2026 | Mark Oldakowski, CHIEF OPERATING OFFICER | Tax Withholding | 27 | $35.10 |
| Jun 4, 2026 | Alka Chaubey, CHIEF MEDICAL OFFICER | Tax Withholding | 24 | $31.20 |
| Jun 4, 2026 | Mark Adamchak, Principal Accounting Officer | Tax Withholding | 7 | $9.10 |